Allegra-D

Allegra-D®

Fexofenadine/pseudoephedrine Allergy medicine A nonsedating antihistamine with a decongestant for relief of seasonal allergic rhinitis. See Allergic rhinitis, Antihistamine.
References in periodicals archive ?
Reddy's Launches OTC, Store-Brand Equivalent of Allegra-D 12 HR Allergy and Congestion Extended-Release Tablets in the US Market
(-0.3%) Market Dollar sales Dollar sales LEADING BRANDS ** share (000) % change Private Label 36.5% $125,030 -3.2% Zyrtec 8.0% 27,403 +0.2% Claritin 5.6% 19,211 +6.2% Allegra 5.1% 17,392 +2.0% Claritin-O 4.7% 16,209 +1.3% Benadryl 4.5% 15,241 +5.6% Allegra-D 3.0% 10,283 -8.4% Mucinex 2.7% 9,257 +10.9% Mucinex DM 2.4% 8,254 -5.9% Zyrtec-D 2.3% 7,980 -1.7% TOTAL UNIT SALES * 79.5 mil.
The company added the OTC Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets 60 mg / 120 mg is the bioequivalent generic version of Allegra-D 12 Hour Allergy & Congestion.
The FDA also approved behind-the-counter sale of Allegra-D 24-hour and 12-hour extended-release tablets, which include the decongestant pseudoephedrine, for patients older than 12 years, according to the company.
Patents on Allegra and Allegra-D, a 12-hour version, expire in 2012 and 2017.
Allegra-D 24 Hour Extended-Release Tablets (fexofenadine HCl 180 mg; pseudoephedrine HCl 240 mg, Aventis Pharmaceuticals Inc.) The Food and Drug Administration approved Allegra-D 24 Hour Extended-Release tablets for relief of symptoms associated with seasonal allergic rhinitis in adults and children 12 years and older.
The letter from the health care plan medical director suggests that Allegra and Allegra-D, both made by Hoechst Marion Roussel, "may be appropriate alternatives" and informs the enrollee that it has notified her doctor about Allegra and Allegra-D and their relative cost to the health care plan.
Allegra has been approved by the Food and Drug Administration for nonprescription sale for adults and children ages 2 and olden Allegra-D, which also relieves nasal congestion and sinus pressure, will be available without a prescription at the pharmacy counter for adults and children 12 and older.
The Allegra family of O-T-C products includes Allegra 24-Hour and 12-Hour Tablets for adults and children 12 years of age and older; Children's Allegra 12-Hour Tablets for 6 years of age and older, and Liquid for use in 2 years of age and older; Children's Allegra 12-Hour Orally Disintegrating Tablets for use in 6 years of age and older; and Allegra-D 24-Hour and 12-Hour Allergy and Congestion Extended Release Tablets (with a decongestant) for use in children 12 years of age and older.
(fexofenadine HCI 180 mg; pseudoephedrine HCl 240 mg, Aventis Pharmaceuticals Inc.) Allegra-D 24 Hour Extended-Release tablets are FDA approved for relief of symptoms associated with seasonal allergic rhinitis in adults and children 12 years and older.
Sanofi-aventis announced that Allegra-D, which also relieves nasal congestion and sinus pressure, will be available without a prescription at the pharmacy counter for use in adults and children 12 and older.
Additionally, the company's Allegra-D, which also relieves nasal congestion and sinus pressure, will be available without a prescription at the pharmacy counter for use in adults and children over 12.